Meetings and Travel Emissions
Cross-source consensus on Meetings and Travel Emissions from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Where it comes from
Highlighted claims
- Meetings and travel was the dominant emission module in both assessed trials, accounting for approximately 67–68% of total CO2e in each. — Assessing the carbon footprint of French academic clinical trials using the NIHR method
- In TOCILAM, nearly the entire meetings-and-travel footprint (2,148 kgCO2e out of 2,151 kgCO2e) derived from a single transatlantic flight by the principal investigator to present results at an international congress in the United States. — Assessing the carbon footprint of French academic clinical trials using the NIHR method
- In REMICRUSH, meetings-and-travel emissions were distributed across CRA travel for multiple monitoring visits to 15 participating sites covering initiations, monitorings, and closures. — Assessing the carbon footprint of French academic clinical trials using the NIHR method
- Virtual or hybrid conference participation is identified as the single most impactful lever for reducing the carbon footprint of small single-centre trials. — Assessing the carbon footprint of French academic clinical trials using the NIHR method
- Expanding remote CRA monitoring or outsourcing site visits to local providers could substantially reduce travel emissions in multicentre trials. — Assessing the carbon footprint of French academic clinical trials using the NIHR method